drugset / Trial / NCT00759811
METhotrexate Therapy Effects in the Physical Capacity of Patients With ISchemic Heart Failure (METIS Trial)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of the study is to evaluate the efficacy of methotrexate to improve physical capacity in patients with symptomatic ischemic heart failure.
Timeline
- Start
- 2007-12
- Primary completion
- 2008-11
- Completion
- 2008-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 7.5 mg | Oral |
| Background | folic acid | Other / unclassified | 5 mg | Oral |